Rohto Pharmaceutical Co.,Ltd. (TYO:4527)
Japan
· Delayed Price · Currency is JPY 2,324.50
+50.50 (2.22%)
Mar 10, 2026, 10:25 AM JST
Rohto Pharmaceutical Revenue
Rohto Pharmaceutical had revenue of 88.81B JPY in the quarter ending December 31, 2025, with 2.30% growth. This brings the company's revenue in the last twelve months to 335.80B, up 13.61% year-over-year. In the fiscal year ending March 31, 2025, Rohto Pharmaceutical had annual revenue of 308.63B with 13.95% growth.
Revenue (ttm)
335.80B
Revenue Growth
+13.61%
P/S Ratio
1.53
Revenue / Employee
36.72M
Employees
9,144
Market Cap
513.84B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 308.63B | 37.79B | 13.95% |
| Mar 31, 2024 | 270.84B | 32.18B | 13.48% |
| Mar 31, 2023 | 238.66B | 39.02B | 19.54% |
| Mar 31, 2022 | 199.65B | 18.36B | 10.13% |
| Mar 31, 2021 | 181.29B | -7.04B | -3.74% |
| Mar 31, 2020 | Pro | Pro | Pro |
| Mar 31, 2019 | Pro | Pro | Pro |
| Mar 31, 2018 | Pro | Pro | Pro |
| Mar 31, 2017 | Pro | Pro | Pro |
| Mar 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Lion Corporation | 422.09B |
| Kobayashi Pharmaceutical | 165.74B |
| KOSE Holdings | 330.19B |
| Pola Orbis Holdings | 170.29B |
| Paltac | 1,227.67B |
| MTG Co., Ltd. | 109.56B |
| Shiseido Company | 969.99B |
| Pigeon | 109.17B |